rs769471844
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_001127198.5(TMC6):c.892-2A>T variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000434 in 1,611,062 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_001127198.5 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Publications
- epidermodysplasia verruciformis, susceptibility to, 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- epidermodysplasia verruciformisInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TMC6 | NM_001127198.5 | c.892-2A>T | splice_acceptor_variant, intron_variant | Intron 8 of 19 | ENST00000590602.6 | NP_001120670.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TMC6 | ENST00000590602.6 | c.892-2A>T | splice_acceptor_variant, intron_variant | Intron 8 of 19 | 2 | NM_001127198.5 | ENSP00000465261.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152124Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000404 AC: 1AN: 247538 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1458938Hom.: 0 Cov.: 34 AF XY: 0.00000276 AC XY: 2AN XY: 725786 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152124Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74302 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
Age Distribution
ClinVar
Submissions by phenotype
Epidermodysplasia verruciformis Pathogenic:1
This sequence change affects an acceptor splice site in intron 8 of the TMC6 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in TMC6 are known to be pathogenic (PMID: 15042430, 17139267). This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individual(s) with epidermodysplasia verruciformis (PMID: 15042430, 36268689). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 4751). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Epidermodysplasia verruciformis, susceptibility to, 1 Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at